azetepa has been researched along with Carcinoma, Bronchogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CHOY, DS; STYLIANOU, S | 1 |
| BATEMAN, JC | 1 |
| MCLEAN, JA | 1 |
3 other study(ies) available for azetepa and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
Clinical experience with a new alkylating agent, azetepa, in a variety of solid tumors.
Topics: Alkylating Agents; Antineoplastic Agents; Azirines; Breast Neoplasms; Carcinoma, Bronchogenic; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Hodgkin Disease; Humans; Neoplasms | 1962 |
CLINICAL STUDIES WITH AZETEPA IN THE TREATMENT OF ADVANCED CANCER.
Topics: Azirines; Bone Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinosarcoma; Ependymoma; Fibrosarcoma; Gastrointestinal Neoplasms; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Mesothelioma; Mouth Neoplasms; Multiple Myeloma; Neoplasms; Nitrogen Mustard Compounds; Pharyngeal Neoplasms | 1964 |
"AZETEPA": A NEW ALKYLATING AGENT.
Topics: Adolescent; Alkylating Agents; Antineoplastic Agents; Azirines; Carcinoma, Bronchogenic; Geriatrics; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms | 1965 |